missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18792947

Human CTLA-4 (Research Grade Ipilimumab Biosimilar) PE-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Human Monoclonal Antibody

Brand:  R&D Systems FAB9928P-100

Product Code. 18792947

  • 464.00 € / 100 tests

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CTLA-4 Monoclonal specifically detects CTLA-4 in Human samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CTLA-4
Monoclonal
PE
Supplied in a saline solution containing BSA and Sodium Azide.
Human
Protein A or G purified from cell culture supernatant
RUO
1493
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied.
IgG1
Flow Cytometry
Hu111
Flow Cytometry 10 uL/10^6 cells
CD, CD152, CD152 antigen, CD152IDDM12, CD28, celiac disease 3, CELIAC3, CTLA4, CTLA-4, cytotoxic T-lymphocyte antigen 4, cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, cytotoxic T-lymphocyte-associated protein 4, cytotoxic T-lymphocyte-associated serine esterase-4, GRD4, GSE, ICOS, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
Human CTLA-4
100 Tests
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.